Cytotoxic Activity of Some Half‐sandwich Rhodium(III) Complexes Containing 4,4’‐disubstituted‐2,2’‐bipyridine Ligands

Abstract

AbstractThe synthesis and characterization of three compounds [Rh(η5‐C5Me5)Cl(N^N)]PF6 (N^N=4,4’‐disubstituted‐2,2’‐bipyridines, 1–3) are described. The cationic complexes contain the bidentate ligands N^N=4,4'‐di‐tert‐butyl‐2,2'‐bipyridine (1), N^N=4,4'‐dinonyl‐2,2'‐bipyridine (2) and N^N=4,4'‐diamino‐2,2'‐bipyridine (3). The complex salts were obtained by the bridge‐splitting reaction from the precursor [{Rh(η5‐C5Me5)(μ‐Cl)Cl}2] and subsequent salt metathesis affording their corresponding hexafluorido phosphate salts. All compounds were characterized by elemental analysis and spectroscopic means. Additionally, the molecular structure of compound 3 in the solid was determined by a single‐crystal X‐ray diffraction study. The cytotoxicity of all three compounds was examined by MTT assay against two cancer cell lines – HT‐29 (colon adenocarcinoma) and MCF‐7 (human breast adenocarcinoma) ‐ and normal human fibroblast cells (GM5657T). Compound 1 has moderate cytotoxicity against both cell lines, while compound 2 is seven to nine times more cytotoxic than cisplatin against MCF‐7 and HT‐29, respectively. In contrast to cisplatin, both compounds are more active against cancer cells than fibroblasts, thus showing some cancer selectivity.